Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human metapneumovirus (HMPV) attachment glycoprotein, or G protein, is a type II transmembrane surface protein essential for the initiation of viral infection. It facilitates the attachment of the virus to host cell receptors, primarily through interactions with glycosaminoglycans such as heparan sulfate on the surface of respiratory epithelial cells (UniProt P0C2Z6). The G protein is heavily glycosylated with both N-linked and O-linked sugars, which helps the virus evade host immune detection by masking antigenic sites and modulating the innate immune response, including the inhibition of type I interferon signaling (Bao et al., 2008, Journal of Virology). Structurally, it consists of an N-terminal cytoplasmic tail, a transmembrane domain, and a large, highly variable C-terminal extracellular domain. This high degree of sequence variability between HMPV lineages A and B makes the G protein a challenging target for universal vaccine development compared to the more conserved fusion (F) protein (Thiempanawong et al., 2021, Viruses). Nevertheless, it remains a critical target for understanding viral pathogenesis and is a key component in the study of HMPV-induced respiratory diseases like bronchiolitis and pneumonia, particularly in pediatric, elderly, and immunocompromised populations.
Neutralization of viral infectivity by blocking the attachment of the virus to host cell surface receptors, such as glycosaminoglycans, thereby preventing viral entry and subsequent replication.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human metapneumovirus attachment glycoprotein (HMPV G).